ArticleJournal of diabetes science and technology2019

Evaluation of the Use of Exenatide Once-Weekly Suspension Autoinjector Among Patients With Type 2 Diabetes Mellitus and Health Care Professionals.

Susan LaRue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.